Coast (OP-501): First in man phase I multicenter study evaluating OPD5 as a myeloablative conditioning regimen in relapsed refractory multiple myeloma (RRMM) Meeting Abstract


Authors: Giralt, S.; Bäck, K.; Norin, S.; Gay, F.
Abstract Title: Coast (OP-501): First in man phase I multicenter study evaluating OPD5 as a myeloablative conditioning regimen in relapsed refractory multiple myeloma (RRMM)
Meeting Title: 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Journal Title: Bone Marrow Transplantation
Volume: 56
Issue: Suppl. 1
Meeting Dates: 2021 Mar 14-17
Meeting Location: Virtual
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2021-06-24
Start Page: 136
End Page: 137
Language: English
ACCESSION: WOS:000668928500111
PROVIDER: wos
DOI: 10.1038/s41409-021-01342-6
Notes: Meeting Abstract: O126 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1051 Giralt